Skip to main content
YARW logo

YARW · Yarrow Bioscience, Inc.

$33.00 +2.55 (+8.37%) At close · Jul 30
Market Cap
$952.56M
Shares
33.35M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2024
Executive Total
David Domzalski $1,973,607
Iain Stuart $908,430
Mutya Harsch $891,515
Fiscal 2023
Executive Total
David Domzalski $2,716,350
Iain Stuart $1,164,946
Mutya Harsch $1,126,090
Fiscal 2022
Executive Total
David Domzalski $1,293,464
Mutya Harsch $654,410
Iain Stuart $653,926
Fiscal 2021
Executive Total
David Domzalski $4,852,925
Mutya Harsch $1,312,106
Iain Stuart $1,287,359
Fiscal 2020
Executive Total
David Domzalski $2,872,008
Steven Basta $1,614,942
Andrew Saik $1,536,537
Mutya Harsch $907,196
Fiscal 2019
Executive Total
Steven Basta $1,878,181
Kristine Ball $898,376
Paul Kwon $892,888
Andrew Saik
Mutya Harsch
David Domzalski
Fiscal 2018
Executive Total
Steven Basta $2,605,865
Kristine Ball $1,265,478

Executive changes

Person Change Filed
all of the Company's directors Resigned 2026-07-28
Anthony Bruno Resigned 2025-08-14
Christine Borowski, Ph.D. Resigned 2025-08-14
Key facts CIK 1566044 CUSIP 92941V308 13F (30d) 7 filings 6 filers Visit website Investor relations